secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aprea Therapeutics, Inc. (APRE)
CIK:        0001781983
Form:       8-K
Filed at:   2024-01-26T23:59:59+00:00
Accession:  0001104659-24-006976
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aprea Therapeutics enters $1.0M at-the-market equity distribution agreement with H.C. Wainwright
--------------------------------------------------------------------------------

- Enters ATM agreement to sell up to $1.0M of common stock through H.C. Wainwright as agent.
- Commission of 3.0% of gross proceeds; net proceeds for general corporate purposes including trials.
- Company not obligated to sell any shares; offering made under Form S-3 filed Jan 26, 2024.
- At-the-market offering allows stock sales at prevailing market prices over time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1781983/000110465924006976/0001104659-24-006976-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1781983/000110465924006976/tm244107d3_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-006976

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer